Statistics on Biotechnology Use Results by fields of operation Total sectors. Biotechnology results by main variables and fields of operation. Unidades: Total 2020 Companies P.A. Higher Education PNPI Companies that perform R+D in Biotechnology 1.430 1.233 118 67 12 %Companies according to biotechnology used: Genetic code 39,1 31,7 89 86,6 41,7 %Companies according to biotechnology used: Functional Companies 45,2 38,5 88,1 91 58,3 %Companies according to biotechnology used: Cellular and tissue culturing and engineering 30,1 22,8 73,7 80,6 75 %Companies according to biotechnology used: Bioprocesses 55,7 53,4 57,6 94 58,3 %Companies according to biotechnology used: Sub-cellular organisms 15,8 8,6 55,9 74,6 33,3 %Companies according to biotechnology used: Bio-computing 29,2 22,3 71,2 85,1 16,7 %Companies according to biotechnology used: Nanobiotechnology 16,6 10,6 50 68,7 8,3 %Companies according to biotechnology used: Other 12,7 14,2 1,7 7,5 0 Companies in which biotechnology activities are: Main and/or exclusive 653 615 29 2 7 Companies in which biotechnology activities are: A secondary line of business 262 178 35 48 1 Companies in which biotechnology activities are: A tool necessary for production 515 440 54 17 4 %Companies by field(s) of ultimate application of biotechnology use: Human health 51 46 77 91 67 %Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture 19 16 19 70 25 %Companies by field(s) of ultimate application of biotechnology use: Food products 33 32 23 79 0 %Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production: 27 25 23 73 33 %Companies by field(s) of ultimate application of biotechnology use: Environment 19 16 23 76 8 %Companies by field(s) of ultimate application of biotechnology use: Industry 16 13 14 70 8 Personnel in R&D in biotechnology (no. of persons) 43.568 13.444 14.558 15.422 144 Personnel in R&D in biotechnology (no. of persons): Researchers 28.824 7.378 8.979 12.379 88 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants 14.744 6.066 5.579 3.043 56 Personnel in R&D in biotechnology (no. of persons): women 24.402 7.501 9.115 7.689 97 Personnel in R&D in biotechnology (no. of persons): (women) Researchers 15.288 4.052 5.262 5.916 58 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants 9.115 3.450 3.853 1.773 39 Personnel in R&D in biotechnology (FTE) 30.003,8 9.401,9 10.846,1 9.663,9 91,9 Personnel in R&D in biotechnology (FTE): Researchers 19.421,7 5.398,3 6.270,9 7.692,1 60,4 Personnel in R&D in biotechnology (FTE): Technicians and assistants 10.582,1 4.003,6 4.575,2 1.971,8 31,5 Personnel in R&D in biotechnology (FTE): women 17.268,4 5.426,2 6.853,1 4.923,3 65,8 Personnel in R&D in biotechnology (FTE): (women) Researchers 10.512,7 3.016,4 3.680,8 3.774,1 41,4 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants 6.755,7 2.409,8 3.172,3 1.149,2 24,4 Internal expenditure on R&D (thousands of euros) 2.059.394 897.333 678.685 477.628 5.748 1) By nature of the expense: Current expenses 1.896.836 817.409 632.188 441.712 5.526 1.1) Remuneration to researchers 815.653 295.705 238.938 279.152 1.859 1.2) Remuneration to technicians and assistants 346.532 156.853 127.778 61.050 851 1.3) Other current expenses 734.651 364.852 265.472 101.510 2.817 2) By nature of the expense: Capital expenses 162.558 79.924 46.497 35.916 221 2.1) Land and buildings 21.618 10.272 4.863 6.483 0 2.2) Equipment and instruments 125.071 56.609 40.467 27.780 216 2.3) Acquisition of specific R+D software 7.349 4.839 969 1.541 1 2.4) Otros productos de propiedad intelectual específicos para I+D 8.519 8.203 199 112 5 1.1) By origin of the funds: Own funds 772.786 613.097 68.653 88.724 2.311 1.2) By origin of the funds: From companies 222.014 86.085 110.014 25.119 796 1.3) By origin of the funds: Public Administration funds 824.067 92.140 416.365 314.573 989 1.4) By origin of the funds: From Universities 6.337 853 1.238 4.246 0 1.5) By origin of the funds: From non profit private institutions 29.754 4.682 15.618 8.422 1.032 1.6) By origin of the funds: Foreign funds 204.436 100.476 66.798 36.544 619 Purchase of services R & D in Biotechnology to (thousands of euros) 114.577 85.011 21.442 7.429 695 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain 81.403 54.243 19.374 7.134 652 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad 33.174 30.768 2.068 294 43 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital 42,2 39,2 61 58,2 75 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information 10,9 11,7 3,4 10,4 8,3 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources 16,2 12,5 41,5 38,8 25 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain 13,6 10,9 29,7 34,3 16,7 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets 17,1 14,3 31,4 41,8 25 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels 19 17 29 40 25 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception 14,5 15 9,3 10,4 33,3 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements 36 36 37 34 58 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost 48,6 46,7 60,2 59,7 66,7 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting 19 19 21,2 13,4 25 %Companies that have requested biotechnology patents in Biotechnology 22,9 17,3 53,4 73,1 8,3 Number of patents requested 1.991 681 698 611 1 Notas: '..'=data not available '.'=numeric piece of data equal to zero not resulting from rounding FTE: Full Time Equivalent (*) Total calculated from the total number of companies with related activities with Biotechnology and the total Companies from other sectors with activities in R&D in Biotechnology Fuente: National Statistics Institute